Serum-Free B27/Neurobasal Neuronal Maintenance Culture

Materials Required

Principle

Serum-free B27/Neurobasal culture is a defined neuronal maintenance method designed to support dissociated primary neurons while limiting serum-driven glial expansion; the readout is sustained neuronal survival, neurite extension, neuronal marker expression, synapse formation, and, when measured, electrophysiological or calcium activity. B27/Neurobasal was optimized in embryonic rat hippocampal neurons, where B27 supported >60% survival after 4 days above 160 plated cells/mm2 and Neurobasal reduced glial growth to <0.5% by immunocytochemistry; later studies extended the approach to cortex, striatum, substantia nigra, septum, cerebellum, and dentate gyrus neurons.

MCE has not independently verified the accuracy of these methods. They are for reference only.

Experimental Materials

• Neurobasal medium with B27 supplement is the core serum-free maintenance medium for primary neuronal culture;
• Published protocols commonly add L-glutamine or GlutaMAX, and some protocols include glutamate only during early plating or early culture.

• Papain or trypsin can be used for enzymatic dissociation of embryonic or neonatal neural tissue, and poly-D-lysine, poly-L-lysine, laminin, Matrigel, PuraMatrix, or glial feeder/sandwich supports have been used as attachment or survival-support substrates depending on the protocol and cell density.

• Neuronal identity and culture purity have been assessed with neuron-specific markers including neurofilament 200, neuron-specific enolase, MAP2, βIII-tubulin, and NeuN;
• Glial contamination has been assessed with GFAP;
• Dopaminergic phenotype has been assessed with tyrosine hydroxylase;
• Synaptic maturation has been assessed with synaptophysin, GluR1, GABA_Aβ, and NMDA-R1 immunoreactivity.

• Reported culture workflows use sterile dissection instruments, cell-culture plates or glass coverslips, incubators for mammalian cell culture, phase-contrast microscopy for morphology, fluorescence microscopy for immunocytochemistry, and, when functional maturation is evaluated, patch-clamp recording, calcium imaging, or microelectrode arrays.

Experimental Procedure

• Prepare dissociated neurons from the reported source tissue only within the validated model range: embryonic rat hippocampus, cortex, striatum, substantia nigra, septum, fetal hindbrain, neonatal dentate gyrus, neonatal cerebellum, or similar published rodent neuronal preparations;
• Avoid extrapolating unsupported tissue ages or species-specific parameters.

• Coat the culture surface with a published neuronal attachment support such as poly-D-lysine/poly-L-lysine with or without laminin, Matrigel, PuraMatrix, or a glial feeder/sandwich configuration;
• Low-density cultures are particularly dependent on coverslip overlay, sandwich culture, three-dimensional support, or trophic support from feeder layers.

• Prepare maintenance medium as Neurobasal plus B27 with glutamine or GlutaMAX when reported;
• For low-density long-term rat hippocampal cultures, Neurobasal/B27/L-glutamine combined with PuraMatrix and a sandwich coverslip supported cultures for >2 months without a glial feeder layer.

• Dissect target neural tissue, remove non-target tissue, enzymatically dissociate the tissue with papain or trypsin as reported, gently triturate to generate a single-cell suspension, and plate cells onto the prepared substrate in serum-free Neurobasal/B27-based medium or in a protocol-specific short initial plating condition followed by transfer to serum-free Neurobasal/B27.

• Use plating densities supported by the literature rather than arbitrary density choices: Brewer et al. reported B27/Neurobasal hippocampal neuron survival above 60% at ≥160 cells/mm2 and >90% 4-week viability at 640 cells/mm2, while lower-density systems required coverslip overlay, sandwich culture, PuraMatrix, or glial feeder support.

• Maintain cultures in serum-free Neurobasal/B27-based medium for days to weeks depending on the experimental endpoint;
• Published endpoints include 4-day survival assays, 10-day fetal hindbrain differentiation, 2-week dopaminergic phenotype maintenance, 3-week cortical/hippocampal neuronal branching, 4-week hippocampal/cortical survival, and >2-month low-density hippocampal culture under PuraMatrix sandwich conditions.

• Assess culture success by phase-contrast morphology, neuronal marker immunostaining, glial marker immunostaining, survival or viability measurements, neurite length or branching, and, where relevant, synaptic marker staining, calcium imaging, patch-clamp recording, or microelectrode-array activity.

• Use biological replicates from independent dissections or culture preparations when reported, compare serum-free B27/Neurobasal cultures with literature-relevant controls such as serum-containing medium, MEM-based medium, glial feeder or no-feeder conditions, or alternative defined supplements, and interpret reduced survival at low density as a condition-dependent limitation rather than a universal failure of the medium.

Troubleshooting

Low survival in sparse cultures:

Published work shows that isolated neurons below common plating-density thresholds have lower survival unless additional local trophic support or physical overlay is provided.
Solution
Increase plating density within the validated range, add a coverslip overlay, use sandwich culture, or use PuraMatrix-based sandwich support when using low-density hippocampal neurons.

Excess glial expansion:

Serum-containing medium promotes glial proliferation in neuronal cultures.
Solution
Maintain neurons in serum-free Neurobasal/B27-based conditions when the goal is neuron-enriched culture, because Brewer et al. reported <0.5% glial growth under optimized B27/Neurobasal conditions.

Poor reproducibility between B27-based cultures:

Defined supplements can vary in neuronal support, and NS21 work attributed much of the variability to albumin source and transferrin form.
Solution
Use a consistent supplement lot or consider a published defined alternative such as NS21 when supplement variability is experimentally problematic.

B27/Neurobasal is unsuitable for oxidative-stress experiments:

B27/Neurobasal contains antioxidant components that can interfere with free-radical injury studies.
Solution
Use a published alternative such as the NM-2 mixture when the study specifically requires reduced antioxidant influence while retaining neuronal survival and low glial proliferation.

References: